IL17A and autoimmune polyendocrinopathy: As shown in Fig 4A, only the levels of IFN-γ and IL-17A, but not IL-4, in the culture medium were significantly lower in the β2-GPI DNA vaccine/FK506 treatment group than in the control APS group.